Clinical trial Recruiting at 1 site Interventional Ages Any age to 12 Months

Aquatic mobility test for infants with SMA

Official title: Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy

Run by Assistance Publique - Hôpitaux de Paris · NCT06152302 · Data updated 2026-11-12

This project will test whether a standardized bath test with wearable inertial sensors can reveal hidden motor abilities in infants with type 1 spinal muscular atrophy.

More Infantile Spinal Muscular Atrophy trials

Quick facts

Study typeInterventional
AgesAny age to 12 Months
SexAll
Enrollment15 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Garches)
StatusRecruiting
StartedJune 26, 2025
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedNovember 21, 2025
Trial IDNCT06152302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants with genetically confirmed SMA type 1 (onset before 6 months), under 12 years and shorter than 90 cm, receiving standard care, and whose parents provide informed consent are ideal candidates.

Probably not a fit

Infants with spinal cord lesions, significant cardiorespiratory disease, those covered by the AME program, or children who already demonstrate sufficient mobility on land may not gain additional information from this test.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter French project will compare infant mobility in standardized dry and in-water conditions using a 'bath test' protocol combined with wearable inertial sensors to detect subtle movements. Infants with genetically confirmed SMA type 1 will be recorded during routine follow-up visits at three pediatric neurology centers coordinated by Raymond Poincaré Hospital. The protocol aims to standardize recording conditions, quantify water-assisted movements, and track changes over time or after therapies. Parental consent is required and common exclusions include spinal cord lesions and significant cardiorespiratory disease.

Why it matters

Potential benefit: If successful, this could reveal previously undetected motor activity and provide a standardized way to track progression or treatment response in severely hypotonic SMA infants.

How similar studies have gone: Pediatric neurologists have used parent-provided bath videos anecdotally and there is emerging interest, but a standardized sensor-based aquatic mobility test is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants with muscle weakness (commonly referred to as floppy babies):

  * Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
  * Receiving standard care.
  * Age less than 12 years and a height of less than 90 cm at the time of inclusion.
* Patients enrolled in a social security scheme.
* Informed consent signed by both parents of the child and the investigator.

Exclusion Criteria:

* Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
* Patients covered under the French Aid in Health for Foreign People program (AME).

Where it's running

  • Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP
    Garches, France
    Recruiting

Study contacts

  • Principal investigator: Susana Quijano-Roy, MD, PhD — Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP
  • Study coordinator: Susana Quijano-Roy, MD, PhD
  • Email: susana.quijano-roy@aphp.fr
  • Phone: + 33 1 47 10 78 90

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.